BlackRock’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8M | Buy |
|
|||||
|
2025
Q1 | $18.3M | Buy |
|
|||||
|
2024
Q4 | $30.4M | Sell |
|
|||||
|
2024
Q3 | $31.8M | Buy |
|
|||||
|
2024
Q2 | $42M | Buy |
|
|||||
|
2024
Q1 | $40.9M | Buy |
|
|||||
|
2023
Q4 | $22.2M | Buy |
|
|||||
|
2023
Q3 | $19.1M | Sell |
|
|||||
|
2023
Q2 | $28.4M | Buy |
|
|||||
|
2023
Q1 | $6.35M | Sell |
|
|||||
|
2022
Q4 | $5.14M | Buy |
|
|||||
|
2022
Q3 | $3.5M | Buy |
|
|||||
|
2022
Q2 | $3.33M | Buy |
|
|||||
|
2022
Q1 | $3.92M | Buy |
|
|||||
|
2021
Q4 | $1.26M | Sell |
|
|||||
|
2021
Q3 | $2.45M | Sell |
|
|||||
|
2021
Q2 | $3.89M | Sell |
|
|||||
|
2021
Q1 | $11.9M | Sell |
|
|||||
|
2020
Q4 | $18.1M | Sell |
|
|||||
|
2020
Q3 | $27.5M | Sell |
|
|||||
|
2020
Q2 | $33.2M | Buy |
|
|||||
|
2020
Q1 | $22M | Buy |
|
|||||
|
2019
Q4 | $29.5M | Sell |
|
|||||
|
2019
Q3 | $36.6M | Buy |
|
|||||
|
2019
Q2 | $56.6M | Buy |
|
|||||
|
2019
Q1 | $36.3M | Buy |
|
|||||
|
2018
Q4 | $17.5M | Sell |
|
|||||
|
2018
Q3 | $35.3M | Buy |
|
|||||
|
2018
Q2 | $36.1M | Buy |
|
|||||
|
2018
Q1 | $27M | Buy |
|
|||||
|
2017
Q4 | $20.1M | Buy |
|
|||||
|
2017
Q3 | $14.3M | Buy |
|
|||||
|
2017
Q2 | $5.99M | Buy |
|
|||||
|
2017
Q1 | $7.09M | Buy |
|
|||||
|
2016
Q4 | $52K | Sell |
|
|||||
|
2016
Q3 | $71K | Hold |
|
|||||
|
2016
Q2 | $65K | Buy |
|
|||||
|
2016
Q1 | $1K | Buy |
|